Medication Adherence in Epileptic Children Follows Socioeconomic Status
Major Finding: Nonadherence rates for antiepileptic medication reached 58% in the first 6 months after epilepsy diagnosis.
Data Source: A 6-month, single-center study of 124 children with newly diagnosed epilepsy.
Disclosures: The study was funded by a grant from the National Institutes of Health. Dr. Modi disclosed that she has been a consultant for Novartis Pharmaceuticals Inc. Another study author disclosed speaker and adviser relationships with companies that manufacture antiepileptic drugs.
FROM JAMA
The investigators limited their focus to sociodemographic and medical factors. In addition, they did not study whether adherence trajectories affected health outcomes. However, this study is part of a longitudinal study, and the investigators noted that they are "currently examining psychosocial factors that contribute to adherence trajectories."
The study was funded by a grant from the National Institutes of Health. Dr. Modi disclosed that she has been a consultant for Novartis Pharmaceuticals Inc. Another study author disclosed speaker and adviser relationships with companies that manufacture antiepileptic drugs.
